Abstract:Background The recognition of new diagnostic and prognostic biological markers for lung cancer, the most severe malignant tumor, is an essential and eager study. In a microenvironment, superoxide dismutase 3 (SOD3) can adjust active oxygen, and it refers to a secreted antioxidant enzyme. It was also found to be cancer-related, and in lung cancer, it was remarkably down-regulated. More and more new cancer research focuses on the function of SOD3. Despite this, there is no good description of SOD3 function in the LC progression. Methods Through bioinformatics analysis, we found that SOD3 was a possible novel lung cancer gene in this study. We analyzed data sets from Gene Expression Comprehensive Database (GEO) and the Cancer Genome Atlas (TCGA), and SOD3 expression was studied in lung cancer. This study estimated the SOD3 diagnosis and prognosis through gene expression differential display, gene set enrichment analysis (GSEA), enrichment and genomes (KEGG) analysis, and gene ontology (GO). Then in order to investigate the SOD3 presentation in lung cancer cells, we used Western Blot and also applied Flow cytometry to detect the impact of anti-tumor medicine on tumor cell apoptosis. Results We found that the expression level of SOD3 in lung cancer was low (P = 4.218E-29), while the survival of lung cancer patients with high SOD3 expression was shorter (LUSC p =0.00086, LUAD p=0.00038). According to the result of western blot, the expression of SOD3 in tumor cells was higher than that in normal cells. The ratio of early apoptosis induced by anti-cancer drugs was 10.5% in normal cells, 35.1% in squamous cell carcinoma and 36.9% in adenocarcinoma.The SOD3 high expression was associated with poor survival probability by multivariate analysis (HR: 1.006, 95% CI 1.002–1.011, p=0.006). Moreover, SOD3 high expression group had higher ESTIMATE scores, and larger amount of immune infiltrating cells. SOD3 expression is correlated with PDCD1 and CTLA4 expression. Conclusions SOD3 gene can be used as a prognostic gene in lung cancer patients, and lung cancer patients with high expression of this gene can reap worse prognostic outcome. It can be used as a new clinical method and prognosticator for lung cancer patients.

Relationship between Superoxide Dismutase and Gastric Cancer

Single-cell Sequencing Analysis Reveals Gastric Cancer Microenvironment Cells Respond Vastly Different to Oxidative Stress.

Mitochondrial Manganese-Superoxide Dismutase Expression in Ovarian Cancer

Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review

Overexpression of Extracellular Superoxide Dismutase 3 Inhibits Cancer Cell Growth and Migration in Colorectal Cancer

The Effect of Extracellular Superoxide Dismutase (SOD3) Gene in Lung Cancer

Interplay between Helicobacter pylori and host gene polymorphisms in inducing oxidative DNA damage in the gastric mucosa

Dynamics of Oxidative Stress in Helicobacter pylori-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer

Clinical Significance of Sod2 and Gstp1 Gene Polymorphisms in Chinese Patients with Gastric Cancer

Clinical significance of DNA and RNA oxidative damage in human gastric mucosa infected with helicobacter py-lori

Oxidative Stress and Stomach Cancer

Reactive oxygen species and gastric carcinogenesis: The complex interaction between Helicobacter pylori and host

Correlation Between Suppressor Genes Promoter Hypermethylation and Chemosensitivity of Gastric Cancer

Imperative connotation of SODs in cancer: Emerging targets and multifactorial role of action

Supplementary Table 1 from Manganese Superoxide Dismutase Polymorphism and Risk of Gastric Lesions, and Its Effects on Chemoprevention in a Chinese Population

Chemiluminescence assay of mucosal reactive oxygen species in gastric cancer, ulcer and antral mucosa

Single Nucleotide Polymorphism of Sod2 to Predict Survival for Chinese Gastric Cancer Patients Received Platinum/Fluorouracil-Based Adjuvant Chemotherapy

Supplementary Table 2 from Manganese Superoxide Dismutase Polymorphism and Risk of Gastric Lesions, and Its Effects on Chemoprevention in a Chinese Population

SOD2 Rs4880 CT/CC Genotype Predicts Poor Survival for Chinese Gastric Cancer Patients Received Platinum and Fluorouracil Based Adjuvant Chemotherapy.

An Oxidative Stress Biomarkers Predict Prognosis in Gastric Cancer Patients Receiving Immune Checkpoint Inhibitor.

Serum Total Superoxide Dismutase Activity as a Predictive Factor in Patients with Hepatocellular Carcinoma